Lukas Bubendorf

Lukas Bubendorf

UNVERIFIED PROFILE

Are you Lukas Bubendorf?   Register this Author

Register author
Lukas Bubendorf

Lukas Bubendorf

Publications by authors named "Lukas Bubendorf"

Are you Lukas Bubendorf?   Register this Author

100Publications

2203Reads

16Profile Views

Predictive potential and need for standardization of PD-L1 immunohistochemistry.

Virchows Arch 2019 Apr 1;474(4):475-484. Epub 2018 Sep 1.

Institute of Pathology, University Hospital Basel, Schönbeinstrasse 40, 4031, Basel, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00428-018-2445-7DOI Listing
April 2019

Tissue microarray analysis delineate potential prognostic role of Annexin A7 in prostate cancer progression.

PLoS One 2018 15;13(10):e0205837. Epub 2018 Oct 15.

Department of Anatomy, Physiology and Genetics, and Institute for Molecular Medicine, Uniformed Services University School of Medicine (USUHS), Bethesda, MD, United States of America.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0205837PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6188866PMC
April 2019

Compressed Sensing Radial Sampling MRI of Prostate Perfusion: Utility for Detection of Prostate Cancer.

Radiology 2019 Mar 1;290(3):702-708. Epub 2019 Jan 1.

From the Department of Radiology (D.J.W., T.J.H., M.R.B., C.G.G., D.T.B.), Department of Urology (C.W.), and Institute of Pathology (L.B.), University Hospital of Basel, 4031 Basel, Switzerland; and Center for Advanced Imaging Innovation and Research, Bernard and Irene Schwartz Center for Biomedical Imaging, Department of Radiology, New York University School of Medicine, New York, NY (T.K.B.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1148/radiol.2018180556DOI Listing
March 2019

Protocols for Tissue Microarrays in Prostate Cancer Studies.

Methods Mol Biol 2018 ;1786:103-116

Institute of Pathology, University Hospital Basel, Basel, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/978-1-4939-7845-8_6DOI Listing
February 2019

Identification of a MET-eIF4G1 translational regulation axis that controls HIF-1α levels under hypoxia.

Oncogene 2018 07 2;37(30):4181-4196. Epub 2018 May 2.

Department of Radiation Oncology, Inselspital, Bern University Hospital, and University of Bern, Bern, 3010, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41388-018-0256-6DOI Listing
July 2018

Detection of ROS1-positive non-small cell lung cancer on cytological specimens using immunocytochemistry.

Cancer Cytopathol 2018 06 16;126(6):421-429. Epub 2018 Feb 16.

Institute of Pathology, University Hospital Basel, Basel, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncy.21983DOI Listing
June 2018

Alveolar herniation in transbronchial lung biopsy: a newly recognised diagnostic pitfall.

Histopathology 2018 03 4;72(4):710-712. Epub 2017 Dec 4.

Institute of Pathology, University Hospital Basel, Basel, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/his.13411DOI Listing
March 2018

Comprehensive Molecular Characterization of Urothelial Bladder Carcinoma: A Step Closer to Clinical Translation?

Eur Urol 2017 12 5;72(6):960-961. Epub 2017 Jul 5.

Institute of Pathology, University Hospital Basel, University of Basel, Basel, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.eururo.2017.06.022DOI Listing
December 2017

Lonely Driver ROS1.

J Thorac Oncol 2017 05;12(5):776-777

Institute of Pathology, University Hospital Basel, Basel, Switzerland. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2017.02.019DOI Listing
May 2017

Influence of hematuria and infection on diagnostic accuracy of urinary LASP1: a new biomarker for bladder carcinoma.

Biomark Med 2017 Apr 14;11(4):347-357. Epub 2017 Mar 14.

Department of Urology, University Hospital Basel, Basel, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/bmm-2016-0348DOI Listing
April 2017

Glycine decarboxylase and HIF-1α expression are negative prognostic factors in primary resected early-stage non-small cell lung cancer.

Virchows Arch 2017 Mar 7;470(3):323-330. Epub 2017 Jan 7.

Division of General Thoracic Surgery, Inselspital, Bern University Hospital, Department of Clinical Research, University of Bern, Murtenstrasse 50, 3008, Bern, Switzerland.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s00428-016-2057-z
Publisher Site
http://dx.doi.org/10.1007/s00428-016-2057-zDOI Listing
March 2017

T-cadherin in prostate cancer: relationship with cancer progression, differentiation and drug resistance.

J Pathol Clin Res 2017 Jan 26;3(1):44-57. Epub 2016 Nov 26.

Department of Biomedicine, Laboratory for Signal Transduction University Hospital Basel Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cjp2.61DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5259566PMC
January 2017

Common Fluorescence In Situ Hybridization Applications in Cytology.

Arch Pathol Lab Med 2016 Dec 4;140(12):1323-1330. Epub 2016 Aug 4.

From the Institute of Pathology, University Hospital Basel, Basel, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5858/arpa.2016-0202-RADOI Listing
December 2016

Moving Towards Minimally Invasive Genomically Based Diagnosis and Monitoring of Bladder Cancer.

Eur Urol 2016 07 4;70(1):83-84. Epub 2016 Mar 4.

Institute of Pathology, University Hospital Basel, University of Basel, Basel, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.eururo.2016.02.050DOI Listing
July 2016

Urothelial Cancer in Renal Transplant Recipients: Incidence, Risk Factors, and Oncological Outcome.

Urology 2016 Feb 8;88:104-10. Epub 2015 Dec 8.

Department of Transplant Immunology & Nephrology, University Hospital Basel, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.urology.2015.10.031DOI Listing
February 2016

Metastatic spread in patients with non-small cell lung cancer is associated with a reduced density of tumor-infiltrating T cells.

Cancer Immunol Immunother 2016 Jan 5;65(1):1-11. Epub 2015 Nov 5.

Department of Biomedicine, Cancer Immunology and Biology, University Hospital and University of Basel, Hebelstrasse 20, 4031, Basel, Switzerland.

View Article

Download full-text PDF

Source
http://link.springer.com/content/pdf/10.1007%2Fs00262-015-17
Web Search
http://link.springer.com/10.1007/s00262-015-1768-3
Publisher Site
http://dx.doi.org/10.1007/s00262-015-1768-3DOI Listing
January 2016

Three Genes to Predict Response to Chemotherapy for Bladder Cancer: Individualised Cancer Care at the Doorstep.

Eur Urol 2015 Dec 13;68(6):968-9. Epub 2015 Aug 13.

Institute of Pathology, University Hospital Basel, University of Basel, Basel, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.eururo.2015.07.050DOI Listing
December 2015

Glutathione S-transferase-pi protein expression in prostate cancer--not always a useful diagnostic tool.

Histopathology 2015 Oct 9;67(4):577-9. Epub 2015 Apr 9.

Institute of Pathology, University of Bonn, Bonn, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/his.12671DOI Listing
October 2015

Screening for ALK in non-small cell lung carcinomas: 5A4 and D5F3 antibodies perform equally well, but combined use with FISH is recommended.

Lung Cancer 2015 Aug 21;89(2):104-9. Epub 2015 May 21.

Institute of Pathology, University Hospital Basel, Schoenbeinstrasse 40, 4031 Basel, Switzerland. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2015.05.012DOI Listing
August 2015

An unexpected cause of diffuse alveolar hemorrhage in a kidney transplant patient.

Respiration 2014 10;87(6):504-7. Epub 2014 Apr 10.

Institute for Pathology, University Hospital Basel, Basel, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000358566DOI Listing
April 2015

EGFR and IGF-1R in regulation of prostate cancer cell phenotype and polarity: opposing functions and modulation by T-cadherin.

FASEB J 2015 Feb 7;29(2):494-507. Epub 2014 Nov 7.

*Department of Biomedicine, Laboratory for Signal Transduction, and Institute of Pathology, University Hospital Basel, University of Basel, Basel, Switzerland; and Hirslanden Klinik St. Anna, Luzern, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1096/fj.14-249367DOI Listing
February 2015

Making cytological diagnoses on digital images using the iPath network.

Acta Cytol 2014 14;58(5):453-60. Epub 2014 Nov 14.

Institute for Pathology, University Hospital Basel, Basel, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000369241DOI Listing
January 2015

Ceramic foam plates: a new tool for processing fresh radical prostatectomy specimens.

Virchows Arch 2014 Dec 17;465(6):637-42. Epub 2014 Oct 17.

Institute of Pathology, University Hospital Basel, Schoenbeinstrasse 40, 4031, Basel, Switzerland,

View Article

Download full-text PDF

Source
http://link.springer.com/content/pdf/10.1007/s00428-014-1665
Web Search
http://link.springer.com/10.1007/s00428-014-1665-8
Publisher Site
http://dx.doi.org/10.1007/s00428-014-1665-8DOI Listing
December 2014

Lungscape: resected non-small-cell lung cancer outcome by clinical and pathological parameters.

J Thorac Oncol 2014 Nov;9(11):1675-84

*Centre Hospitalier Universitaire de Vaud, Lausanne, Switzerland; †Division of Thoracic Surgery, University Hospital Zurich, Zurich, Switzerland; ‡Frontier Science Foundation-Hellas & University of Athens, Athens, Greece; §Aberdeen Royal Infirmary, Aberdeen, United Kingdom; ‖Institute for Pathology, University Hospital Basel, Basel, Switzerland; ¶Department of Oncology, University Hospital, Aarhus, Denmark; #Department of Medical Oncology, St. James's Hospital, Dublin, Ireland; **Medical University of Gdansk, Gdansk, Poland; ††University Hospital KU Leuven, Leuven, Belgium; ‡‡Vall d'Hebron University Hospital, Barcelona, Spain; §§Center of Predictive Molecular Medicine, University Foundation, Chieti, Italy; ‖‖Shanghai Lung Cancer Center, Shanghai Chest Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, People's Republic of China; ¶¶VU University Medical Center, Amsterdam, Netherlands; ##Maastricht University Medical Centre, Maastricht, Netherlands; ***Manchester University and The Christie National Health Services Foundation Trust, Manchester, United Kingdom; †††Netherlands Cancer Institute, Amsterdam, Netherlands; ‡‡‡Department of Medicine, University of Valencia and Department of Medical Oncology, General University Hospital of Valencia, Valencia, Spain; §§§Catalan Institute of Oncology, Hospital Germans Trias i Pujol, Badalona, Spain; and ‖‖‖Clinic of Oncology, University Hospital Zurich, Zurich, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0000000000000320DOI Listing
November 2014

Multicenter immunohistochemical ALK-testing of non-small-cell lung cancer shows high concordance after harmonization of techniques and interpretation criteria.

J Thorac Oncol 2014 Nov;9(11):1685-92

*Institute of Pathology, Charité BERLIN, Berlin, Germany; †Institute of Pathology, University of Heidelberg, Heidelberg, Germany; ‡Department of Pathology, Aberdeen University Medical School, Aberdeen, United Kingdom; §Department of Pathology and Cytology, Karolinska University Hospital, Solna, Stockholm, Sweden; ‖Department of Pathology, University Hospital Cologne, Cologne, Germany; ¶Laboratorio de Dianas Terapeuticas, Hospital Universitario Sanchinarro, Madrid, Spain; #Institute of Pathology, Klinikum Großhadern Ludwig-Maximilians-Universität, Munich, Germany; **Institute of Pathology, UZ ANTWERPEN, Edegem, Belgium; ††Institute of Pathology, Klinikum rechts der Isar, TU, Munich, Germany; ‡‡Institute of Pathology, University Hospital Carl Gustav Carus, Dresden, Germany; §§Institute of Pathology, Universitätsspital Basel, Basel, Germany; ‖‖Institute of Pathology, HSK Dr.-Horst-Schmidt-Kliniken GmbH, Wiesbaden, Germany; ¶¶Institute of Pathology, Universitäts Spital Zürich, Zurich, Switzerland; ##Institute of Pathology, Centre Jean Perrin, Clermont-Ferrand, France; ***Patologisk Institut, Århus Universitetshospital, Århus, Denmark; †††Pathology-Berlin, Bioptisches Institut Gemeinschaftspraxis für Pathologie, Berlin, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0000000000000332DOI Listing
November 2014

Maximum tumor diameter adjusted to the risk profile predicts biochemical recurrence after radical prostatectomy.

Virchows Arch 2014 Oct 17;465(4):429-37. Epub 2014 Aug 17.

Department of Urology, University Hospital Basel, Spitalstrasse 21, 4031, Basel, Switzerland,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00428-014-1643-1DOI Listing
October 2014

Prevalence and clinical outcomes for patients with ALK-positive resected stage I to III adenocarcinoma: results from the European Thoracic Oncology Platform Lungscape Project.

J Clin Oncol 2014 Sep 28;32(25):2780-7. Epub 2014 Jul 28.

Fiona H. Blackhall and Daisuke Nonaka, Manchester University and The Christie National Health Services Foundation Trust, Manchester; Keith M. Kerr, Aberdeen University Medical School, Aberdeen Royal Infirmary, Aberdeen, United Kingdom; Solange Peters and Igor Letovanec, Centre Hospitalier Universitaire Vaudois, Lausanne; Lukas Bubendorf and Spasenija Savic, Institute for Pathology, University Hospital Basel, Basel; Alex Soltermann and Rolf A. Stahel, University Hospital Zurich, Zurich, Switzerland; Urania Dafni, Frontier Science Foundation-Hellas and University of Athens, Athens, Greece; Henrik Hager, University Hospital, Aarhus, Denmark; Kenneth J. O'Byrne, St James's Hospital, Dublin, Ireland; Christoph Dooms, University Hospital KU Leuven, Leuven, Belgium; Aleksandra Sejda, Medical University of Gdansk, Gdansk, Poland; Javier Hernández-Losa, Vall d'Hebron University Hospital, Barcelona; Miguel Martorell, Universitat de Valencia and Hospital General Universitario de Valencia, Valencia; Rafael Rosell, Catalan Institute of Oncology, Hospital Germans Trias i Pujol, Badalona, Spain; Antonio Marchetti, Center of Predictive Molecular Medicine, University Foundation, Chieti, Italy; Qiang Tan, Shanghai Lung Cancer Center, Shanghai Chest Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, People's Republic of China; Erik Thunnissen, VU University Medical Clinic Center; Jeroen de Jong, Netherlands Cancer Institute, Amsterdam; Ernst-Jan M. Speel, Maastricht University Medical Centre, Maastricht, the Netherlands; and Richard Cheney, Roswell Park Cancer Institute, Buffalo, NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2013.54.5921DOI Listing
September 2014

MED12 overexpression is a frequent event in castration-resistant prostate cancer.

Endocr Relat Cancer 2014 Aug 17;21(4):663-75. Epub 2014 Jun 17.

Department of Prostate Cancer ResearchInstitute of PathologyUniversity Hospital of Bonn, Sigmund-Freud Strasse 25, 53127 Bonn, GermanyInstitute for PathologyUniversity Hospital Basel, Basel, SwitzerlandDepartment of UrologySt. Claraspital, Basel, SwitzerlandDepartment of UrologyUniversity Hospital Basel, Basel, SwitzerlandDepartment of UrologyUniversity Hospital of Örebro, Örebro, SwedenSchool of Health and Medical SciencesÖrebro University, Örebro, SwedenCenter for Genomics and TranscriptomicsCeGaT GmbH, Tuebingen, GermanyClinic for Urology and Pediatric UrologyUniversity Hospital of Bonn, Sigmund-Freud Strasse 25, 53127 Bonn, GermanySection of Molecular UrooncologyDepartment of Urology, School of Medicine, University of Heidelberg, Heidelberg, GermanyDepartment of Prostate Cancer ResearchInstitute of PathologyUniversity Hospital of Bonn, Sigmund-Freud Strasse 25, 53127 Bonn, GermanyInstitute for PathologyUniversity Hospital Basel, Basel, SwitzerlandDepartment of UrologySt. Claraspital, Basel, SwitzerlandDepartment of UrologyUniversity Hospital Basel, Basel, SwitzerlandDepartment of UrologyUniversity Hospital of Örebro, Örebro, SwedenSchool of Health and Medical SciencesÖrebro University, Örebro, SwedenCenter for Genomics and TranscriptomicsCeGaT GmbH, Tuebingen, GermanyClinic for Urology and Pediatric UrologyUniversity Hospital of Bonn, Sigmund-Freud Strasse 25, 53127 Bonn, GermanySection of Molecular UrooncologyDepartment of Urology, School of Medicine, University of Heidelberg, Heidelberg, Germany

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1530/ERC-14-0171DOI Listing
August 2014

MED15, encoding a subunit of the mediator complex, is overexpressed at high frequency in castration-resistant prostate cancer.

Int J Cancer 2014 Jul 9;135(1):19-26. Epub 2013 Dec 9.

Department of Prostate Cancer Research, University Hospital of Bonn, Bonn, Germany; Institute of Pathology, University Hospital of Bonn, Bonn, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ijc.28647DOI Listing
July 2014

Heterogeneity of ERG expression in core needle biopsies of patients with early prostate cancer.

Hum Pathol 2013 Dec 26;44(12):2727-35. Epub 2013 Sep 26.

Institute for Pathology Liestal, Cantonal Hospital Baselland, CH-4410 Liestal, Switzerland. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.humpath.2013.07.019DOI Listing
December 2013

Characterization and clinical relevance of ALDHbright populations in prostate cancer.

Clin Cancer Res 2013 Oct 22;19(19):5361-71. Epub 2013 Aug 22.

Authors' Affiliations: ICFS, Departments of Surgery and Biomedicine, Department of Urology, Institute for Pathology, Basel University Hospital; Division of Urology, St Claraspital, Basel; and Department of Urology, University of Bern, Bern, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-12-2857DOI Listing
October 2013

Treatment and detection of ALK-rearranged NSCLC.

Lung Cancer 2013 Aug 12;81(2):145-54. Epub 2013 Jun 12.

Department of Oncology, University Hospital of Vaudois (CHUV), Lausanne, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2013.03.017DOI Listing
August 2013

Klf4 transcription factor is expressed in the cytoplasm of prostate cancer cells.

Eur J Cancer 2013 Mar 22;49(4):955-63. Epub 2012 Oct 22.

Institute for Surgical Research and Hospital Management, Department of Biomedicine, Basel University Hospital, Basel, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2012.09.023DOI Listing
March 2013

Role of fluorescence in situ hybridization in lung cancer cytology.

Acta Cytol 2012 24;56(6):611-21. Epub 2012 Nov 24.

Institute for Pathology, University Hospital Basel, Basel, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000339792DOI Listing
February 2013

Clonal evolution and therapeutic resistance in solid tumors.

Front Pharmacol 2013 28;4. Epub 2013 Jan 28.

The Translational Genomics Research Institute Scottsdale, AZ, USA ; Mayo Clinic Arizona Scottsdale, AZ, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fphar.2013.00002DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3556559PMC
February 2013

Genomic analysis and selected molecular pathways in rare cancers.

Phys Biol 2012 Dec 29;9(6):065004. Epub 2012 Nov 29.

Norris Comprehensive Cancer Center, Division of Medical Oncology, University of Southern California, Los Angeles, CA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1088/1478-3975/9/6/065004DOI Listing
December 2012

UroVysion® multiprobe FISH in the triage of equivocal urinary cytology cases.

Ann Pathol 2012 Dec 24;32(6):e52-6, 438-43. Epub 2012 Nov 24.

Institute for Pathology, University Hospital Basel/University of Basel, Schönbeinstrasse 40, 4031 Basel, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.annpat.2012.09.207DOI Listing
December 2012

Application of personalized medicine to solid tumors: opportunities and challenges.

Swiss Med Wkly 2012 19;142:w13587. Epub 2012 Jun 19.

Institute for Pathology, University Hospital Basel, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4414/smw.2012.13587DOI Listing
October 2012

PAGE4 positivity is associated with attenuated AR signaling and predicts patient survival in hormone-naive prostate cancer.

Am J Pathol 2012 Oct 10;181(4):1443-54. Epub 2012 Aug 10.

Institute for Biomedical Aging Research, Austrian Academy of Sciences, Innsbruck, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ajpath.2012.06.040DOI Listing
October 2012